ClinConnect ClinConnect Logo
Search / Trial NCT04021940

Dose Adjusted vs. Fixed Dose Unilateral Laparoscopic Ovarian Drilling in PCOS Patients

Launched by HATEM ABUHASHIM · Jul 13, 2019

Trial Information

Current as of May 12, 2025

Unknown status

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of PCOS will be based on the revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS and its modification (ESHRE, 2018).
  • CCR will be considered if persistent anovulation with 150 mg CC daily for 5 days per cycle, for at least three cycles.
  • Only patients with a phenotype characterized by oligomenorrhoea/anovulation, hyperandrogenaemia and polycystic ovaries on ultrasound examination (PCOM) and a phenotype characterized by oligomenorrhoea/anovulation and PCOM will be enrolled in the study.
  • Age: 20-34 years.
  • Body mass index \< 30 kg/m2
  • Patent fallopian tubes by hysterosalpingography.
  • Normal semen analysis of husbands.
  • Exclusion Criteria:
  • Age ≥ 35 years.
  • BMI ≥ 30
  • Previous history of LOD
  • PCOS phenotypes with regular menses or without PCOM ovaries on USS.
  • Other causes of infertility
  • Women with adrenal hyperplasia, thyroid disease, Cushing's syndrome, hyperprolactinemia and a tumor-related excess of androgen.

About Hatem Abuhashim

Hatem Abuhashim is a dedicated clinical trial sponsor with a focus on advancing medical research and improving patient outcomes. With a commitment to ethical practices and rigorous scientific standards, he leads initiatives that explore innovative therapies and treatment modalities across various therapeutic areas. Leveraging a robust network of healthcare professionals and research institutions, Hatem Abuhashim ensures the successful execution of clinical trials, fostering collaboration and transparency while prioritizing participant safety and data integrity. His expertise and leadership in the field contribute significantly to the advancement of evidence-based medicine.

Locations

Patients applied

0 patients applied

Trial Officials

Hatem Abu Hashim, MD. FRCOG. PhD

Study Chair

Faculty of Medicine, Mansoura University

Eman Lotfy, MBBCh

Principal Investigator

New Mansoura General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials